학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 30건 | 목록
1~20
Academic Journal
In Cell 1999 99(7):747-755
Academic Journal
Geddie ML; Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA.; Research & Development, Diagonal Therapeutics, Cambridge, Massachusetts, USA.; Kirpotin DB; Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA.; Research & Development, Akagera Medicines, San Francisco, CA, USA.; Kohli N; Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA.; Janssen Research & Development, Spring House, Pennsylvania, USA.; Kornaga T; Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA.; Boll B; Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA.; Drug Product Design, ten23 Health, Basel, Switzerland.; Razlog M; Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA.; Research, Verseau Therapeutics, Bedford, Massachusetts, USA.; Drummond DC; Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA.; Research & Development, Akagera Medicines, San Francisco, CA, USA.; Lugovskoy AA; Discovery, Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts, USA.; Research & Development, Diagonal Therapeutics, Cambridge, Massachusetts, USA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Academic Journal
mAbs (1942-0862); Jul/Aug2015, Vol. 7 Issue 4, p752-758, 7p
Academic Journal
Geddie, Melissa L; Kohli, Neeraj; Kirpotin, Dmitri B; Razlog, Maja; Jiao, Yang; Kornaga, Tad; Rennard, Rachel; Xu, Lihui; Schoerberl, Birgit; Marks, James D; Drummond, Daryl C; Lugovskoy, Alexey A
mAbs, vol 9, iss 1
Academic Journal
Zhang, Kathy; Geddie, Melissa L; Kohli, Neeraj; Kornaga, Tad; Kirpotin, Dmitri B; Jiao, Yang; Rennard, Rachel; Drummond, Daryl C; Nielsen, Ulrik B; Xu, Lihui; Lugovskoy, Alexey A
mAbs (1942-0862); Jan/Feb2015, Vol. 7 Issue 1, p42-52, 11p
Academic Journal
Finlay WJJ; a mAbs , London , UK.; Lugovskoy AA; a mAbs , London , UK.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Beck A; Centre d'Immunologie Pierre Fabre; Saint-Julien en Genevois, France.; Carter PJ; Genentech Inc.; South San Francisco, CA USA.; Gerber HP; Pfizer Inc.; New York, NY USA.; Lugovskoy AA; Merimack; Pharmaceuticals, MA USA.; Wurch T; Institut de Recherches SERVIER; Croissy-sur-Seine, France.; Junutula JR; Genentech Inc.; South San Francisco, CA USA.; Kontermann RE; Institute of Cell Biology and Immunology; University of Stuttgart; Stuttgart, Germany.; Mabry R; Adimab LLC; Lebanon, NH USA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Academic Journal
Xu L; Merrimack Pharmaceuticals, Inc. Cambridge, MA, USA.; Kohli N; Rennard R; Jiao Y; Razlog M; Zhang K; Baum J; Johnson B; Tang J; Schoeberl B; Fitzgerald J; Nielsen U; Lugovskoy AA
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Academic Journal
Lugovskoy AA; Merrimack Pharmaceuticals Inc.; Cambridge, MA USA.; Reichert JM; Landes Bioscience; Austin, TX USA.; Beck A; Centre d'Immunologie Pierre Fabre; Saint-Julien en Genevois, France.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Academic Journal
Camblin AJ; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA. adam.camblin@gmail.com.; Tan G; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Curley MD; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Yannatos I; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Iadevaia S; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Rimkunas V; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Mino-Kenudson M; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Bloom T; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Schoeberl B; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Drummond DC; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Lugovskoy AA; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Louis CU; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA.; Askoxylakis V; Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA. v.askoxylakis@gmail.com.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Casaletto JB; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Geddie ML; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Abu-Yousif AO; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Masson K; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Fulgham A; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Boudot A; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Maiwald T; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Kearns JD; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Kohli N; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Su S; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Razlog M; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Raue A; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139; araue@merrimack.com gavin.macbeath@gmail.com.; Kalra A; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Håkansson M; SARomics Biostructures AB, Medicon Village, SE-223 81 Lund, Sweden.; Logan DT; SARomics Biostructures AB, Medicon Village, SE-223 81 Lund, Sweden.; Welin M; SARomics Biostructures AB, Medicon Village, SE-223 81 Lund, Sweden.; Chattopadhyay S; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Harms BD; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Nielsen UB; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Schoeberl B; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; Lugovskoy AA; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139.; MacBeath G; Discovery Division, Merrimack Pharmaceuticals, Inc., Cambridge, MA 02139; araue@merrimack.com gavin.macbeath@gmail.com.
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Kamoun WS; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Kirpotin DB; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Huang ZR; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Tipparaju SK; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Noble CO; Merrimack Pharmaceuticals, Cambridge, MA, USA.; ZoneOne Pharma, San Francisco, CA, USA.; Hayes ME; Merrimack Pharmaceuticals, Cambridge, MA, USA.; ZoneOne Pharma, San Francisco, CA, USA.; Luus L; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Koshkaryev A; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Kim J; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Olivier K; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Kornaga T; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Oyama S; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Askoxylakis V; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Pien C; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Kuesters G; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Dumont N; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Lugovskoy AA; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Schihl SA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Wilton JH; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Geddie ML; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Suchy J; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Grabow S; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Kohli N; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Reynolds CP; Cancer Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA.; Blaydes R; Cancer Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA.; Zhou Y; University of California at San Francisco, San Francisco, CA, USA.; Sawyer AJ; Merrimack Pharmaceuticals, Cambridge, MA, USA.; Marks JD; University of California at San Francisco, San Francisco, CA, USA.; Drummond DC; Merrimack Pharmaceuticals, Cambridge, MA, USA. ddrummond@merrimack.com.
Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE
Academic Journal
He MM; Sunesis Pharmaceuticals, Incorporated, 341 Oyster Point Boulevard, South San Francisco, CA 94080, USA.; Smith AS; Oslob JD; Flanagan WM; Braisted AC; Whitty A; Cancilla MT; Wang J; Lugovskoy AA; Yoburn JC; Fung AD; Farrington G; Eldredge JK; Day ES; Cruz LA; Cachero TG; Miller SK; Friedman JE; Choong IC; Cunningham BC
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
Academic Journal
Camblin AJ; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts. acamblin@merrimack.com VAskoxylakis@merrimack.com.; Pace EA; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Adams S; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Curley MD; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Rimkunas V; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Nie L; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Tan G; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Bloom T; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Iadevaia S; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Baum J; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Minx C; Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York.; Czibere A; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Louis CU; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Drummond DC; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Nielsen UB; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Schoeberl B; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Pipas JM; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.; Straubinger RM; Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York.; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Askoxylakis V; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts. acamblin@merrimack.com VAskoxylakis@merrimack.com.; Lugovskoy AA; Merrimack Pharmaceuticals, Inc., Cambridge, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Fitzgerald JB; Corresponding Authors: Alexey A. Lugovskoy, Merrimack Pharmaceuticals, One Kendal Square, Suite B7201, Cambridge, MA 02139. alugovskoy@merrimackpharma.com.; Johnson BW; Baum J; Adams S; Iadevaia S; Tang J; Rimkunas V; Xu L; Kohli N; Rennard R; Razlog M; Jiao Y; Harms BD; Olivier KJ Jr; Schoeberl B; Nielsen UB; Lugovskoy AA
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Harms BD; Merrimack Pharmaceuticals Inc., 1 Kendall Sq., Ste. B7201, Cambridge, MA 02139, USA. Electronic address: bharms@merrimackpharma.com.; Kearns JD; Merrimack Pharmaceuticals Inc., 1 Kendall Sq., Ste. B7201, Cambridge, MA 02139, USA.; Iadevaia S; Merrimack Pharmaceuticals Inc., 1 Kendall Sq., Ste. B7201, Cambridge, MA 02139, USA.; Lugovskoy AA; Merrimack Pharmaceuticals Inc., 1 Kendall Sq., Ste. B7201, Cambridge, MA 02139, USA. Electronic address: alugovskoy@merrimackpharma.com.
Publisher: Academic Press Country of Publication: United States NLM ID: 9426302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9130 (Electronic) Linking ISSN: 10462023 NLM ISO Abbreviation: Methods Subsets: MEDLINE
Academic Journal
Yin S; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Genetics Medicine, 120 Mason Farm Road, Chapel Hill, NC 27599-7260, USA.; Proctor EA; Lugovskoy AA; Dokholyan NV
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Wang N; Biogen Idec, San Diego, California 92122, USA.; Smith WF; Miller BR; Aivazian D; Lugovskoy AA; Reff ME; Glaser SM; Croner LJ; Demarest SJ
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8700181 Publication Model: Print Cited Medium: Internet ISSN: 1097-0134 (Electronic) Linking ISSN: 08873585 NLM ISO Abbreviation: Proteins Subsets: MEDLINE
Academic Journal
Zhong W; Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. wzhong@cdc.gov; Dixit SB; Mallis RJ; Arthanari H; Lugovskoy AA; Beveridge DL; Wagner G; Reinherz EL
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 2985088R Publication Model: Print-Electronic Cited Medium: Print ISSN: 0022-2836 (Print) Linking ISSN: 00222836 NLM ISO Abbreviation: J Mol Biol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Lugovskoy, Alexey A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어